Antagonists of the serotonin receptor 5A target human breast tumor initiating cells

BACKGROUND: Breast tumor initiating cells (BTIC) are stem-like cells that initiate and sustain tumor growth, and drive disease recurrence. Identifying therapies targeting BTIC has been hindered due primarily to their scarcity in tumors. We previously reported that BTIC frequency ranges between 15% a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwynne, William D., Shakeel, Mirza S., Girgis-Gabardo, Adele, Kim, Kwang H., Ford, Emily, Dvorkin-Gheva, Anna, Aarts, Craig, Isaac, Methvin, Al-awar, Rima, Hassell, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404930/
https://www.ncbi.nlm.nih.gov/pubmed/32758183
http://dx.doi.org/10.1186/s12885-020-07193-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404930/
https://www.ncbi.nlm.nih.gov/pubmed/32758183
http://dx.doi.org/10.1186/s12885-020-07193-6

Ejemplares similares